CDKN1A and prostate neoplasm: For example, CDKN1A is reported as one of a two-gene signature, which could distinguish indolent prostate tumor from aggressive tumor, and accurately predict outcome of low Gleason score prostate tumors35, the other is able to predict survival of castration-resistant PCa36.